Single User License: $3,900.00
Multi User License: $5,850.00
Enterprise License: $7,800.00
Intravenous Immunoglobulin (IVIg) Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast period 2019-2025. The Global Intravenous Immunoglobulin (IVIg) Industry Report gives an elaborate information about the market size, share and analyzes the complete value chain the report also covers the market dynamics enriching business strategists with quality data about the Intravenous Immunoglobulin (IVIg) market.
This research report categorizes the global Intravenous Immunoglobulin (IVIg) market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.
North America region is the largest supplier of intravenous immunoglobulin (IVIg), with a production market share nearly 48% in 2016. Europe is the second largest supplier of intravenous immunoglobulin (IVIg), enjoying production market share nearly 23% in 2016.
North America is the largest sales place, with a sales market share nearly 44% in 2016. Following North America, Europe is the second largest sales place with the sales market share of 22%.
Market competition is intense. Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
In 2017, the global Intravenous Immunoglobulin (IVIg) market size was 8120 million US$ and is forecast to 12800 million US in 2025, growing at a CAGR of 5.9% from 2018. The objectives of this study are to define, segment, and project the size of the Intravenous Immunoglobulin (IVIg) market based on company, product type, application and key regions.
The various contributors involved in the value chain of Intravenous Immunoglobulin (IVIg) include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Intravenous Immunoglobulin (IVIg) include
1 Study Coverage
1.1 Intravenous Immunoglobulin (IVIg) Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Type
1.4.2 IVIg Liquid
1.4.3 IVIg Powder
1.5 Market by Application
1.5.1 Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Application
1.5.2 Immunodeficiency
1.5.3 Autoimmune Disease
1.5.4 Acute Infection
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Intravenous Immunoglobulin (IVIg) Market Size
2.1.1 Global Intravenous Immunoglobulin (IVIg) Revenue 2016-2025
2.1.2 Global Intravenous Immunoglobulin (IVIg) Sales 2016-2025
2.2 Intravenous Immunoglobulin (IVIg) Growth Rate by Regions
2.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Regions
2.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Intravenous Immunoglobulin (IVIg) Sales by Manufacturers
3.1.1 Intravenous Immunoglobulin (IVIg) Sales by Manufacturers
3.1.2 Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturers
3.1.3 Global Intravenous Immunoglobulin (IVIg) Market Concentration Ratio (CR5 and HHI)
3.2 Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers
3.2.1 Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2016-2018)
3.2.2 Intravenous Immunoglobulin (IVIg) Revenue Share by Man ...
Main Categories